None listed
Conditions
Brief summary
This study is investigating how children with juvenile arthritis experience pain after receiving a steroid injection into their joints. We are testing whether it is practical and reliable to collect information about their pain and recovery directly from children and their parents. The study will also explore how factors like anxiety or previous experiences affect pain perception. We hypothesise that it is feasible to collect meaningful patient- and parent-reported data following intra-articular steroid injections.
Interventions
Brief Name:
“Pilot study Assessing Post-Procedural Pain in Children with Juvenile Idiopathic Arthritis Following Intra-Articular Steroid Injections: A Questionnaire-Based Study”
Description of Intervention/Exposure:
This is a single-site, prospective study investigating post-procedural pain and recovery in children with juvenile idiopathic arthritis (JIA) undergoing intra-articular steroid injection (IASI) with the routine use of intra-articular lignocaine administered at the time of injection.
Brief Name: “Pilot study Assessing Post-Procedural Pain in Children with Juvenile Idiopathic Arthritis Following Intra-Articular Steroid Injections: A Questionnaire-Based Study” Description of Intervention/Exposure: This is a single-site, prospective study investigating post-procedural pain and recovery in children with juvenile idiopathic arthritis (JIA) undergoing intra-articular steroid injection (IASI) with the routine use of intra-articular lignocaine administered at the time of injection. Procedure details: All participants will receive a single intra-articular steroid injection under sedation, as part of standard clinical care. Immediately after the steroid is administered, a dose of intra-articular lignocaine will be injected into the joint to provide local analgesia as part of their standard treatment.. The specific joint injected (e.g. knee, ankle, wrist, elbow) and any procedural variables (e.g. difficulty of injection, number of attempts) will be recorded. Duration of observation: Children will be followed for 30 hours post-procedure, with assessments conducted at 1, 2, 4, and 24–30 hours after IASI via structured caregiver interviews. Data collection methods: Data will be collected on pain scores (using age-appropriate scales), anxiety levels (child and caregiver), use of analgesics or mobility aids, and return to physical activities and school. Data will be obtained via telephone contact with the primary caregiver. Personnel involved: IASI procedures and lignocaine administration will be performed by trained paediatric rheumatologists. Consent and Follow-up assessments will be conducted by the independent research team. Location: Procedures will occur at the Royal Children’s Hospital (RCH), Melbourne, and follow-up will be completed remotely. Assessment of fidelity: This study embedded in routine care, no intervention fidelity measures apply. Procedural details will be captured in medical records and confirmed during data collection.
Sponsors
Royal children's Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
Each participant must meet all the following criteria to be enrolled in this study: - Aged between 6 and 18 years at the time of enrolment. - Has a confirmed diagnosis of Juvenile Idiopathic Arthritis (JIA), based on the International League of Associations for Rheumatology (ILAR) classification criteria. - Scheduled to undergo elective intra-articular steroid injection of a single joint under procedural sedation at the Royal Children’s Hospital. - Single joint injections will include the Knee, elbow, wrist and ankle joints only. - Is medically stable and able to participate in post-procedural follow-up over a 24-hour period. - Has a parent or legally authorized representative capable of understanding the study information and providing written informed consent. - Where age-appropriate, the participant can provide verbal or written assent.
Exclusion criteria
Participants meeting any of the following criteria at baseline will be excluded from this study: - Has a developmental delay or cognitive impairment that would preclude reliable self-reporting or caregiver-assisted completion of pain assessments (as determined by the treating clinician). - Will receive general anesthesia for the intra-articular steroid injection, rather than the standard procedural sedation protocol involving nitrous oxide and topical anesthetic. - Has planned IASI of more than a single joint. - Has a known hypersensitivity or contraindication to any medication used in the procedure, including nitrous oxide, topical anesthetics (e.g., EMLA or equivalent), or intra-articular lignocaine. - Is experiencing an acute febrile illness or active infection at the time of the scheduled procedure that may compromise safety or interfere with pain reporting. - Has a clinically diagnosed psychiatric condition (e.g., severe anxiety disorder, psychosis, or behavioral disorder) in either the child or the primary caregiver that would interfere with participation, communication, or follow-up. - Has a co-morbid condition with a life expectancy of less than 6 months or any condition that would preclude meaningful follow-up within 24 hours post-procedure. - Has a history of receiving another clinical intervention within the last 30 days that may interfere with pain perception, anxiety scores, or general recovery patterns (e.g., surgery, clinical drug trials). - Is unable or unwilling to return pain or follow-up data during the 24-hour post-procedural period (e.g., due to planned travel or lack of contact access). - Refusal or inability of the participant and/or their legally authorized representative to provide written informed consent (and assent where appropriate). - Has limited English proficiency without access to a translator or translated questionnaires, where this would compromise the validity or reliability of data collected.
Outcome results
None listed